Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Chinese Journal of Oncology ; (12): 592-594, 2002.
Article in Chinese | WPRIM | ID: wpr-301928

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the treatment modalities and the prognostic factors of nasal cavity carcinoma.</p><p><b>METHODS</b>A retrospective study was done on 60 nasal cavity carcinoma patients treated from 1985 to 1992. Thirty-four patients received radiotherapy alone and 26 patients received surgery plus radiotherapy. Kaplan-Meier method was used to evaluate the survival, Log-rank test to assess the difference between these two groups and Cox proportional hazard model by multivariate analysis.</p><p><b>RESULTS</b>The overall 5- and 10-year survival rates were 55.9% and 36.9% respectively. The 5- and 10-year survival rates were 79.0% and 57.9% in patients with early lesions (stage I, II) and 44.1% and 26.0% in patients with advanced lesions (stage III, IV) (P = 0.005). There was no significant difference in the survival rate between radiotherapy alone and radiotherapy plus surgery (P = 0.33). Patients with squamous cell carcinoma had obviously poorer survival rate than patients with adenocarcinoma (P = 0.04). Patients with positive nodes had a lower survival rate compared with negative node patients (P = 0.09).</p><p><b>CONCLUSION</b>Histological type and clinical stage, but not method of treatment or neck node metastasis, are the important prognostic factors.</p>


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Combined Modality Therapy , Lymphatic Metastasis , Multivariate Analysis , Nasal Cavity , Neck , Neoplasm Staging , Nose Neoplasms , Diagnosis , Mortality , Radiotherapy , General Surgery , Prognosis , Retrospective Studies , Survival Rate
2.
Chinese Journal of Radiation Oncology ; (6)1992.
Article in Chinese | WPRIM | ID: wpr-551471

ABSTRACT

Purpose: To report the treatment result for lung cancer with brain metastasis. Materials and Methods: 117 patients with brain metastases from lung cancers were treated by radiotherapy alone or surgery followed by radiotherapy from January, 1987 to December, 1993. Radiotherapy were given with the dose of 23~40Gy (whole brain irradiation) then followed with 15~24Gy booster. Results: The median survival period and one year survival rate were 9.5 months and 62.5% in surgery plus radiotherapy group and 5.7 months and 14.2% in radiotherapy alone group(P

SELECTION OF CITATIONS
SEARCH DETAIL